Endocyte and Seattle Children’s Research Institute to Collaborate on Endocyte’s Small Molecule Drug Conjugate Bi … – Yahoo Finance
Post Analyst |
Endocyte and Seattle Children’s Research Institute to Collaborate on Endocyte’s Small Molecule Drug Conjugate Bi …
Yahoo Finance The aim of the research collaboration is to join Endocyte’s SMDC bi-specific adaptor technology with the CAR T-cell immunotherapy research efforts at the Ben Towne Center for Childhood Cancer Research at Seattle Children’s Research Institute, to move … Endocyte Reports Fourth Quarter and Year End 2016 Financial Results and Provides Clinical and Pipeline UpdateNasdaq |
FierceBiotech |
Gene Therapy Developer Tocagen Files for $86M IPO
Genetic Engineering & Biotechnology News (press release) Tocagen, a gene therapy developer focused on treating brain cancer, will seek to raise $86 million through an initial public offering, according to an S-1 registration statement filed with the U.S. Securities and Exchange Commission. Tocagen’s lead … Tocagen seeks $86M IPO to fund cancer gene therapy trialFierceBiotech Tocagen readies IPOSeeking Alpha |
|
CAR T Cell Therapy Market, By Targeted Antigen, Therapeutic Application, and Geography – Trends, Analysis and …
Medgadget (blog) CAR T cell therapy has been a major buzzword for a while, owing to its effectiveness in treating blood cancer. These are the genetically engineered receptors that targets surface molecules in patient’s immune system. T cells are collected from patients … |
BioPharma-Reporter.com |
Pfizer mulls sites for NC gene therapy plant year after Bamboo buy
BioPharma-Reporter.com Kim Bencker, head of communications at Pfizer Global supply, told us in an emailed statement “We recently announced that we’re moving forward with scoping potential sites in Sanford for our new gene therapy site. She added: “This work is still in the … |
MIT Technology Review |
The Download, Mar 10, 2017: CRISPR Viable Embryo Test, WikiLeaks’ Hollow Offer, and Safer Drone Crashes
MIT Technology Review The Download, Mar 10, 2017: CRISPR Viable Embryo Test, WikiLeaks’ Hollow Offer, and Safer Drone Crashes. The most fascinating and important news in technology and innovation delivered straight to your inbox, every day. by Jamie Condliffe; March 10, … |
MIT Technology Review |
The Download, Mar 10, 2017: CRISPR Viable Embryo Test, WikiLeaks’ Hollow Offer, and Safer Drone Crashes
MIT Technology Review The Download, Mar 10, 2017: CRISPR Viable Embryo Test, WikiLeaks’ Hollow Offer, and Safer Drone Crashes. The most fascinating and important news in technology and innovation delivered straight to your inbox, every day. by Jamie Condliffe; March 10, … |